Effect of telehealth on glycaemic control: Analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Steventon, Adam ^a   Bardsley, Martin ^a   Doll, Helen ^b   Tuckey, Elizabeth ^a   Newman, Stanton P ^c  

^a Health Education England   (United Kingdom)

^b ICON PLC   (United Kingdom)

^c CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AGED; BLOOD; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84906536524     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-334     Document Type: Article

References (49)

1. Bardsley M, Steventon A, Smith J, Dixon J, Evaluating Integrated and Community-Based Care: How Do We Know What Works? London: Nuffield Trust 2013
2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, Diabetes Care 2012 35 1364 1379
3. Quality of care of people with type 2 diabetes in eight European Countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Stone MA, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten G, Trento M, Khunti K, Diabetes Care 2013 36 2628 2638
4. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Clar C, Barnard K, Cummins E, Royle P, Waugh N, Health Technol Assess 2010 14 1 140
5. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin. Kempf K, Tankova T, Martin S, Diabetes Technol Ther 2013 15 89 96
6. Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes. Virdi NS, Lefebvre P, Parisé H, Duh MS, Pilon D, Laliberté F, Sundaresan D, Garber L, Dirani R, J Diabetes Sci Technol 2013 7 1229 1242
7. Telehealthcare for long term conditions. McLean S, Protti D, Sheikh A, BMJ 2011 342 120
8. Goal setting using telemedicine in rural underserved older adults with diabetes: experiences from the informatics for diabetes education and telemedicine project. West SP, Lagua C, Trief PM, Izquierdo R, Weinstock RS, Telemed J E Health 2010 16 405 416
9. Department of Health, Our Health, Our Care, Our Say: A New Direction for Community Services. Cm 6737 London: The Stationery Office 2006
10. Home telehealth for diabetes management: a systematic review and meta-analysis. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Diabetes Obes Metab 2009 11 913 930
11. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, Morin P, Goland R, Izquierdo RE, Wolff LT, Ashraf M, Hilliman C, Silver S, Meyer S, Holmes D, Petkova E, Capps L, Lantigua RA, J Am Med Inform Assoc 2006 13 40 51
12. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study. Weinstock RS, Teresi JA, Goland R, Izquierdo R, Palmas W, Eimicke JP, Ebner S, Shea S, Diabetes Care 2011 34 274 279
13. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, Lai AM, Field L, Morin PC, Goland R, Izquierdo RE, Ebner S, Silver S, Petkova E, Kong J, Eimicke JP, J Am Med Inform Assoc 2009 16 446 456
14. A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial. Bower P, Cartwright M, Hirani SP, Barlow J, Hendy J, Knapp M, Henderson C, Rogers A, Sanders C, Bardsley M, Steventon A, Fitzpatrick R, Doll H, Newman S, BMC Health Serv Res 2011 11 184
15. Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Bergmo TS, Cost Eff Resour Alloc 2009 7 18
16. Understanding controlled trials: What are pragmatic trials? Roland M, Torgerson DJ, BMJ 1998 316 285 285
17. Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Beynon M, Hirani SP, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Hendy J, Fitzpatrick R, Newman S, Age Ageing 2013 42 501 508
18. The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial. Hirani SP, Beynon M, Cartwright M, Rixon L, Doll H, Henderson C, Bardsley M, Steventon A, Knapp M, Rogers A, Bower P, Sanders C, Fitzpatrick R, Hendy J, Newman SP, Age Ageing 2013 43 334 341
19. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Fitzpatrick R, Hendy J, Newman S, BMJ 2012 344 3874
20. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Rogers A, Fitzpatrick R, Barlow J, Newman SP, BMJ 2013 346 1 20
21. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. Henderson C, Knapp M, Fernandez J-L, Beecham J, Hirani SP, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, Doll H, Fitzpatrick R, Steventon A, Bardsley M, Hendy J, Newman SP, BMJ 2013 346 1035 f1035
22. An organisational analysis of the implementation of telecare and telehealth: the whole systems demonstrator. Hendy J, Chrysanthaki T, Barlow J, Knapp M, Rogers A, Sanders C, Bower P, Bowen R, Fitzpatrick R, Bardsley M, Newman S, BMC Health Serv Res 2012 12 403
23. Exploring barriers to participation and adoption of telehealth and telecare within the Whole System Demonstrator trial: a qualitative study. Sanders C, Rogers A, Bowen R, Bower P, Hirani S, Cartwright M, Fitzpatrick R, Knapp M, Barlow J, Hendy J, Chrysanthaki T, Bardsley M, Newman SP, BMC Health Serv Res 2012 12 220
24. Experiences of front-line health professionals in the delivery of telehealth: a qualitative study. MacNeill V, Sanders C, Fitzpatrick R, Hendy J, Barlow J, Knapp M, Rogers A, Bardsley M, Newman SP, Br J Gen Pract 2014 64 401 e407
25. Current development in clinical trials: issues old and new. DeMets DL, Stat Med 2012 31 2944 2954
26. NHS Employers and General Practitioners Committee, Quality and Outcomes Framework Guidance for GMS Contract 2009 / 10 London: NHS Employers 2009
27. Impact of telehealth on general practice contacts: findings from the Whole Systems Demonstrator cluster randomised trial. Bardsley M, Steventon A, Doll H, BMC Health Serv Res 2013 13 395
28. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. Puffer S, Torgerson DJ, Watson J, BMJ 2003 327 785
29. Misunderstandings between experimentalists and observationalists about causal inference. Imai K, King G, Stuart EA, J R Stat Soc Ser A (Stat Soc) 2008 171 481 502
30. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Austin PC, Stat Med 2009 28 3083 3107
31. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Frison L, Pocock SJ, Stat Med 1992 11 1685 1704
32. Survival as a function of HbA (1c) in people with type 2 diabetes: a retrospective cohort study. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD, Lancet 2010 375 481 489
33. Wennberg D, Siegel M, Darin B, Filipova N, Russell R, Kenney L, Steinort K, Park T-R, Cakmakci G, Dixon J, Curry N, Billings J, Combined Predictive Model: Final Report and Technical Documentation London: King's Fund 2006
34. Pragmatic randomised trials using routine electronic health records: putting them to the test. Staa T-P v, Goldacre B, Gulliford M, Cassell J, Pirmohamed M, Taweel A, Delaney B, Smeeth L, BMJ 2012 344 55 e55
35. Research in home-care telemedicine: challenges in patient recruitment. Subramanian U, Hopp F, Lowery J, Woodbridge P, Smith D, Telemed J E Health 2004 10 155 161
36. Designing assisted living technologies "in the wild": preliminary experiences with cultural probe methodology. Wherton J, Sugarhood P, Procter R, Rouncefield M, Dewsbury G, Hinder S, Greenhalgh T, BMC Med Res Methodol 2012 12 188
37. The use of propensity scores to assess the generalizability of results from randomized trials. Stuart EA, Cole SR, Bradshaw CP, Leaf PJ, J R Stat Soc Ser A (Stat Soc) 2011 174 369 386
38. The Hawthorne Effect: a randomised, controlled trial. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P, BMC Med Res Methodol 2007 7 30
39. Asynchronous and Synchronous Teleconsultation for Diabetes Care. Verhoeven F, Tanja-dijkstra K, Nijland N, Sc M, Eysenbach G, Van G-p L, J Diabetes Sci Technol 2010 4 666 684
40. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, Huang J, Wang L, Gu D, Diabet Med 2011 28 455 463
41. The impact of telehealthcare on the quality and safety of care: a systematic overview. McLean S, Sheikh A, Cresswell K, Nurmatov U, Mukherjee M, Hemmi A, Pagliari C, PLoS One 2013 8 71238
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. The Diabetes Control and Complications Trial Research Group, N Engl J Med 1993 329 977 986
43. 10-year follow-up of intensive glucose control in type 2 diabetes. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW, N Engl J Med 2008 359 1577 1589
44. Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Govan L, Wu O, Briggs A, Colhoun HM, Fischbacher CM, Leese GP, McKnight JA, Philip S, Sattar N, Wild SH, Lindsay RS, Diabetes Care 2011 34 1992 1997
45. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Ray KK, Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N, Lancet 2009 373 1765 1772
46. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M, Control Group, Diabetologia 2009 52 2288 2298
47. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N, Nutr Metab Cardiovasc Dis 2009 19 604 612
48. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis. Boussageon R, Bejan-angoulvant T, BMJ 2011 343 4169
49. HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes. Lipska KJ, Warton EM, Huang ES, Moffett HH, Inzucchi SE, Krumholz HM, Karter AJ, Diabetes Care 2013 36 3535 3542